S0637B0716A02377 DMS:NLG 06/27/17 #90 A02377
AMENDMENTS TO SENATE BILL NO. 637
Sponsor: SENATOR WHITE
Printer's No. 716
Amend Bill, page 1, lines 12 and 13, by striking out all of
said lines and inserting
providing for pharmaceutical pricing transparency.
Amend Bill, page 1, lines 19 through 23; page 2, lines 1
through 27; by striking out all of said lines on said pages and
inserting
Section 635.8. Pharmaceutical Pricing Transparency.--(a)
The Insurance Department shall annually collect information on
pharmaceutical retail pricing.
Amend Bill, page 2, line 28, by striking out "(c)" and
inserting
(b)
Amend Bill, page 2, line 29, by striking out "commission" and
inserting
department
Amend Bill, page 4, by inserting between lines 15 and 16
(vi) The aggregate amount of all rebates that the
manufacturer has provided to all payers, including, but not
limited to, insurers and pharmacy benefit managers, for the sale
of each drug within this Commonwealth.
Amend Bill, page 4, line 20, by striking out "(d)" and
inserting
(c)
Amend Bill, page 4, line 20, by striking out "(c)" and
inserting
(b)
2017/90DMS/SB0637A02377 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Amend Bill, page 4, lines 23 through 30, by striking out all
of said lines and inserting
(d) A health insurer shall include the aggregate amount of
rebates it has received from pharmacy benefit managers or drug
manufacturers for the preceding calendar year in its annual
statement filed with the department. The department shall verify
that all such rebates are passed on to an insurer's customer in
any rate filing with the department.
(e) Pharmacy benefit manager or insurer contracts with
pharmacies may not contain a provision that prohibits
pharmacists from disclosing information to a customer that would
reduce the customer's out-of-pocket costs for prescription
drugs.
Amend Bill, page 5, line 1, by striking out "The commission,
in conjunction with the" and inserting
The
Amend Bill, page 5, line 2, by striking out the comma after
"Department"
Amend Bill, page 5, line 4, by inserting after "section."
The department may only include in the public report the
aggregate amount of rebates paid for each drug and shall not
disclose the identity of any individual payer.
(g) For purposes of this section , the term "manufacturer"
does not include a person that engages in a business that only
repackages or relabels prescription drugs.
Section 2. This act shall apply to any new or renewed
contract on or after January 1, 2018.
Amend Bill, page 5, line 5, by striking out "2" and inserting
3
2017/90DMS/SB0637A02377 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
See A02377 in
the context
of SB0637